2000
DOI: 10.1016/s0925-4439(99)00108-8
|View full text |Cite
|
Sign up to set email alerts
|

Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines

Abstract: Hybrid cells created by fusion of antigen presenting and tumour cells have been shown to induce potent protective and curative anti-tumour immunity in rodent cancer models. The application of hybrid cell vaccines for human tumour therapy and the timely intervention in disease control are limited by the requirement to derive sufficient autologous cells to preserve homologous tumour antigen presentation. In this study, the efficiency of various methods of electrofusion in generating hybrid human cells have been … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
50
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(51 citation statements)
references
References 55 publications
1
50
0
Order By: Relevance
“…+ cells have resulted in hybrid cells capable of efficient growth [22] and whole cell vaccines have been produced in this manner for several different tumours [19][20][21]. Use of human allogeneic DCs fused with tumour cells has shown more promising results [32,33].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…+ cells have resulted in hybrid cells capable of efficient growth [22] and whole cell vaccines have been produced in this manner for several different tumours [19][20][21]. Use of human allogeneic DCs fused with tumour cells has shown more promising results [32,33].…”
Section: Discussionmentioning
confidence: 99%
“…The electrofusion method was based upon findings of Scott-Taylor et al . [22]. B-CLL B cells and dendritic cells were resuspended in 0·3 M sodium sucrose solution at a cell density of 5 ¥ 10 5 /ml; 0·4 ml of B-CLL B cells and dendritic cells were added to a 0·8-ml electro-plated cuvette (Bio-Rad).…”
Section: Fusion Of Dendritic Cells and B-cll B Cellsmentioning
confidence: 99%
“…The fusion of DCs and A673s has the advantage that the antigen does not need to be identified [28,30,34,35]. Hybrid DCs can present all the antigens of the entire tumor cell to effector cells, especially the tumor antigens that have not been identified but might be crucial to tumor immunity.…”
Section: Discussionmentioning
confidence: 99%
“…Electrofusion was carried out by an ECM 830 (BTX Instruments, Human Disease Genomics Center, Peking University). Fused cells were allowed to rest for 5 minutes [30,36]. Then, they would either immediately undergo fluorescence activated cell sorting (FACS) analysis for assessing percentage of hybrids or be cultured overnight.…”
Section: Methodsmentioning
confidence: 99%
“…The hybridoma is then able to continue to grow in culture, and a large amount of specific desired antibodies can be recovered after processing. Electrofusion has proved to be a successful approach in the production of vaccines Orentas et al (2001);Scott-Taylor et al (2000), antibodies Schmidt et al (2001), and reconstructed embryos in mammalian cloning Gaynor et al (2005).…”
Section: Electrofusion (Ef)mentioning
confidence: 99%